Treatment	Cause	Edge Weight	Shared Publications
COPD Treatment Cluster 31: Optimizing NIV and HFNC Strategies for COPD Patients with Respiratory Acidosis and Hypercapnia	COPD Cause Cluster 2: Interplay between Occupational Hazards and Respiratory Mechanics in COPD Pathophysiology	0.08847184986595175	33
COPD Treatment Cluster 31: Optimizing NIV and HFNC Strategies for COPD Patients with Respiratory Acidosis and Hypercapnia	COPD Cause Cluster 15: Sleep-Related Pathophysiology and Environmental Exposures in COPD Etiology and Progression	0.037109375	19
COPD Treatment Cluster 31: Optimizing NIV and HFNC Strategies for COPD Patients with Respiratory Acidosis and Hypercapnia	COPD Cause Cluster 3: Environmental and Inflammatory Modulators of Acute COPD Exacerbation Risk and Severity	0.024282560706401765	11
COPD Treatment Cluster 31: Optimizing NIV and HFNC Strategies for COPD Patients with Respiratory Acidosis and Hypercapnia	COPD Cause Cluster 7: Congenital and Interstitial Lung Diseases as Modifiers of Emphysema and Fibrosis in COPD	0.00998003992015968	5
COPD Treatment Cluster 31: Optimizing NIV and HFNC Strategies for COPD Patients with Respiratory Acidosis and Hypercapnia	COPD Cause Cluster 35: Cardiovascular and Metabolic Comorbidities as Modifiable Risk Factors for COPD Exacerbation	0.008620689655172414	4
COPD Treatment Cluster 31: Optimizing NIV and HFNC Strategies for COPD Patients with Respiratory Acidosis and Hypercapnia	COPD Cause Cluster 29: Racial and Socioeconomic Disparities in Ambient Air Pollution and COPD Burden	0.006928406466512702	6
COPD Treatment Cluster 31: Optimizing NIV and HFNC Strategies for COPD Patients with Respiratory Acidosis and Hypercapnia	COPD Cause Cluster 30: Modulating Bronchial Inflammation in Cystic Fibrosis-Related COPD: Environmental, Genetic, and Therapeutic Interactions	0.005847953216374269	3
COPD Treatment Cluster 31: Optimizing NIV and HFNC Strategies for COPD Patients with Respiratory Acidosis and Hypercapnia	COPD Cause Cluster 37: Acute Lung Injury and Inflammatory Dysregulation as Precursors to COPD Progression and Exacerbation	0.005115089514066497	2
